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Abstract
The carcinogenic effect of benzene is associated with metabolites produced in benzene metabolism 
such as phenol, catechol, quinones, muconic acid (tt-MA), and phenyl mercapturic acid (s-PMA). The 
role of CYP4502E1 enzyme in benzene metabolism is very important, which is determined by its genetic 
polymorphism. This cross-sectional study is aimed to obtain the distribution of frequency of s-PMA concentration 
in workers who had been low exposure of benzene based on CYP4502E1 genetic polymorphism. The study 
was conducted between September 2007 and April 2010. Data were collected by methods of interviews, 
physical examinations, laboratory examinations, and direct observation on the work place. The variables 
studied were CYP4502E1, benzene exposure at the work place, age, type of work, history of work, length of 
work, body mass index (BMI), antioxidants intake, behavior and management, and s-PMA concentration in 
the urine. The distribution of CYP4502E1 genetic polymorphism in workers is 87.8% wild type homozygote, 
11.3% heterozygote and 0.9% mutant homozygote. There was no significant difference in the proportion of 
s-PMA concentration based on CYP4502E1 genetic polymorphism  (p=0.595; ORraw=0.98; 95% CI=0.95-
1.01). There were also no differences of age, type of work, length of work, BMI, antioxidants consumptions, 
behavior and management of subjects with s-PMA. Further study should be conducted on CYP4502E1 
genetic polymorphism in various Indonesian races at different workplace with low-level benzene.
Key words: low-level benzene exposure;CYP4502E1; s-PMA.
Peran Polimorfisme Genetik CYP4502E1
pada Metabolisme Benzena
Abstrak: 
Efek karsinogenik juga berhubungan dengan proses metabolisme benzena yang menghasilkan metabolit 
seperti fenol, katekol, qinon,asam mukonik (tt-MA), dan asam fenil merkapturik (s-PMA). Peran enzim 
CYP4502E1 dalam metabolisme benzena sangat penting, yang ditentukan oleh  polimorfisme genetiknya. 
Penelitian dengan desain potong lintang ini bertujuan melihat distribusi konsentrasi s-PMA diantara pekerja 
yang terpajan benzena rendah berdasarkan polimorfisme genetik CYP4502E1. Penelitian dilakukan pada bulan 
September 2007 sampai April 2010. Data dikumpulkan dengan wawancara, pemeriksaan fisik, pemeriksaan 
laboratorium dan observasi langsung di lingkungan kerja. Variabel yang diukr adalah CYP4502E1, pajanan 
benzena di lingnkungan kerja, umur,jenis pekerjaan, riwayat pekerjaan, masa kerja, indeks massa tubuh, 
asupan antioksidan, kebiasaan dan  manajemen, dan konsentrasi s-PMA dalam urin. Distribusi Polimorfisme 
genetik CTP4502E1 pada pekerja adalah 87.8% wild type homozygote, 11.3% heterozygote and 0.9% 
mutant homozygote. Tidak ada perbedaan proporsi antara konsentrasi s-PMA berdasarkan polimorfisme 
genetik CYP4502E1 (p=0.595; ORraw=0.98; 95% CI=0.95-1.01). Tidak ada juga perbedaan dari umur, jenis 
pekerjaan, masa kerja, indeks massa tubuh, konsumsi antioksidan, kebiasaan dan manajemen dari s-PMA 
pekerja. Penelitian lanjut perlu dilakukan untuk melihat polimorfisme genetik CYP4502E1 tiap suku bangsa di 
Indonesian di lingkungan kerja yang terpajan benzena rendah.
Kata Kunci: pajanan benzena rendah; CYP4502E1; s-PMA.
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Introduction 
Benzene has been known as one of substances 
with genotoxic and carcinogenic characteristics; 
however, it is still widely used at the workplace. 
Benzene metabolism produces several metabolites 
such as phenol, catechol, quinones, trans-trans 
muconic acid (tt-MA) and s-phenyl mercapturic acid 
(s-PMA). Phenol, catechol and quinones metabolites 
subsequently produce free radicals leading to 
peroxidation reaction with cell, particularly the 
lymphocytes.1,2  
The metabolism of benzene in the body requires 
CYP4502E1 enzyme and disturbance of this enzyme 
will have effects to its metabolism which means also 
influences the concentration of its metabolites. One 
of benzene metabolites which is recommended as a 
marker of low-level exposure of benzene (<1ppm) is 
s-PMA.2-4 It has been known that genetic polymorphism 
of CYP4502E1 gives different expressions in different 
ethnics and such study has not been performed in 
Indonesia. The present study is aimed to recognize 
CYP4502E1 genetic polymorphism of Indonesian 
workers who had low-level benzene exposure and its 
correlation with s-PMA concentration as a marker of 
benzene metabolism. 
Methods
The present study has utilized cross-sectional 
design in 115 full-time workers who worked at the 
production and administration division of the head 
office. The study has been approved by the Ethical 
Committee of Faculty of Medicine, Universitas 
Indonesia. Samples were randomly selected and were 
stratified based on their workplace. Of a total 210 male 
workers, we found 11 (9.6%) workers were exposed to 
benzene more than 0.1ppm and 104 (90.4%) workers 
were exposed to benzene either equal or less than 
0.1ppm. The study site was at an oil company in East 
Kalimantan, Indonesia. The study was conducted 
between September 2007 and April 2010.   
Data of subject characteristics were collected 
by interview techniques using questionnaire. The 
interviews were performed by investigator, company 
physicians and paramedic at the study site every 
workday. Observations were carried out on utilization 
of self-protection tools, behavior of the workers 
when using the self-protection tools (mask, work-
suit, goggle, and gloves) during their working hour, 
warning sign and standard of procedure at work 
location exposed to benzene. The observations 
also included data collection on the structure 
of organization, production flow, facilities at the 
workplace and type of work for each worker. 
All observations were performed by investigators 
aided by the company physicians and nurses. 
The CYP4502E1 genetic polymorphism blood 
examinations were performed by polymerase 
chain reaction (PCR) method at the Departments 
of Biochemistry and Molecular Biology, Faculty of 
Medicine Universitas Indonesia.  The examination 
of benzene concentration at the workplace was 
performed by passive sampler method and 
biomonitoring of urin s-PMA in Australia Laboratorium 
Services, Kuala Lumpur, Malaysia.
Data analysis were performed to obtain overall 
view of subject characteristics, CYP4502E1 genetic 
polymorphism and the concentration of  s-PMA. 
The proportion of s-PMA concentration was based 
on age group, type of work, history of work, body 
mass index, length of work, antioxidants intake, 
behavior and management, the concentration of 
benzene on air at the work place. CYP4502E1 
genetic poymorphism was analyzed by X2 test and 
odds ratio crude (ORcrude) and 95% confidence 
interval were determined.5-7 
Results 
Subject Characteristics 
The median age of subjects was 30 years old; 
the youngest was 18 years old and the oldest was 
55 years old. The median value for the length of 
work was 7 years with the shortest duration was 1 
year and the longest was 34 years. Behavior and 
management aspects included a compilation of 
preventive measures by using mask and sanction 
was put in effect if the mask was not used. The 
behavior and management were classified as 
appropriate and less appropriate. Our study found 
that 81(70.4%) subjects had appropriate   behavior 
and management and the other 34 (29.6%) subjects 
had less appropriate behavior and management.
The body mass index (BMI) in the study were 
grouped into obesity, overweight, normal weight 
and underweight. In this study, 42(36.52%) subjects 
had BMI of obesity, 34(29.57%) subjects had 
excessive BMI indicating overweight, 35(30.43%) 
subjects had normal BMI and 4(3.48%) subjects 
had BMI less than normal. Distribution of frequency 
for subject characteristics, benzene exposure, and 
urine s-PMA are presented on Table 1.
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Table 1. Subject Distribution  of Characteristic 
Subject and Benzene Exposure
Characteristic and Benzene Exposure n %
Age
    < 30 years 71 61.7
    >30 years 44 38.3
Type of Occupation
   Administration 25 21.7
   Production 90 78.3
Length of work
   1-10 years 87 75.6
   >10 years 28 24.4
Occupation history        
   No 49 42.6
   Yes 66 57.4
Body mass index
   Obesity 42 36.5
   Overweight 34 29.6
   Normoweight 35 30.4
   Underweight 4  3.5
Antioxidant resources
   High 83 72.2
   Low 32 27.8
Behavior and management
   Appropiate 81 70.4
   Less appropiate 34 29.6
Benzene exposure in the workplace 
(passive sampler)
   <0.1 ppm 104 90.4
   >0.1 ppm 11 9.6
Biological Monitoring of Benzene Exposure by 
Measuring s-PMA 
The median for s-PMA, a benzene metabolite, 
was 9 ug/g creatinine, with minimum value was 0 and 
maximum value was 31ug/g creatinine. The quantity 
of benzene metabolites measured by urinary s-PMA 
was categorized into more than 25ug/g creatinine 
and equal/less than 25ug/g creatinine. There were 
2(1.74%) subjects with urinary s-PMA concentration 
above 25ug/g creatinine, and 113(98.26%) subjects 
who had urinary s-PMA concentration equal/less 
than 25ug/g creatinine.
The Profile of CYP4502E1 Genetic Polymorphism 
The CYP4502E1 is an enzyme that has 
important role in benzene metabolism which 
occurs in the liver. In our study, the genetic 
polymorphism of CYP4502E1 was grouped into 
wild-type homozygote, heterozygote and mutant 
homozygote. The results demonstrated that 
101(87.8%) subjects had wild-type homozygote, 
13(11.3%) subjects was heterozygote and 1(0.9%) 
subject had mutant homozygote. 
From 115 total subjects, wild-type homozygote 
was found in 101(87.8%) subjects measured by 
202 C1 alleles (dominant allele); while heterozygote 
was found in 13(11.3%) subjects with 13 C1 alleles 
(dominant allele) and 13 C2 alleles (mutant allele) 
and one subject (0.9%) had mutant homozygote 
with 2 C2 alleles (mutant allele). The total alleles 
are 230 with the quantity of C1 allele (dominant 
allele) was 215 alleles (93.48%), and C2 allele 
(mutant allele) was 15 alleles (5.52%). Further 
details can be seen on Table 2.
Table 2. Distribution of Genetic Polymorphysm 
CYP4502E1 Based on  Genotype Quantity 
and Alleles Quantity
Genetic 
Polymorphysm  
Genotype 
quantity
Alleles 
C1
Alleles 
C2
Homozygot wild 
type (C1C1)
101 202 -
Heterozygot 
(C1C2) 
13 13 13
Homozygot mutan 
(C2C2) 
1 - 2
Total 115 215 15
Proportional  Comparison of S-PMA Concentration 
The results of bivariate analysis between 
subjects and urinary s-PMA are presented on Table 
3. All characteristic of subjects had no significant 
difference with s-PMA concentration (p>0.05)
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Table 3.  Correlation between Characteristic and s-PMA Benzene Metabolite
Characteristics
s-PMA 
< 25ug/g creatinine
s-PMA
> 25ug/g creatinine
OR
crude CI 95% p
   n % n %
Age
   <30 years 70  98.6 1 1.4
1.63 0.09-26.71 0.621
   >30 years 45  97.7 1 2.3
Type of Occupation
   Administration 25 100 0 0
1.02 0.99-1.07 0.611
   Production 88  97.8 2 2.2
Length of work
   1-10 years 86  98.9 1 1.1
3.19 0.19-52.66 0.429   >10 years 27  96.4 1 3.6
Occupation history        
   No 65 98.5 1 1.5
1.35 0.08-22.2 0.673
   Yes 48 98 1 2
Body mass index
   Obesity*   4 100 0 0
0.51 0.03-8.33 1.000
   Overweight* 34  97.1 1 2.9
   Normoweight** 34 100 0 0
   Underweight**   41  97.6 1 2.4
Antioxidant resources
   High 81  97.6 2 2.4
0.98 0.94-1.01 0.519
   Low 32 100 0 0
Behavior and
management
   Appropiate 79  97.5 2 2.5
0.98 0.94-1.01 0.494
   Less appropiate 34 100 0 0
Note: *be added in the analysis, ** be added in the analysis
In order to recognize whether there was 
any correlation between CYP4502E1 genetic 
polymorphism and urinary s-PMA metabolites, 
a bivariate analysis was performed. The results 
showed that there was no significant difference 
between CYP4502E1 genetic polymorphism with 
the concentration of urinary s-PMA metabolites in 
all subjects (p=0.595; ORcrude= 0.98; 95%CI =0.95-
1.01). Further details are expressed on Table 4. 
Table 4. Correlation between Genetic Polymorfphysm CYP4502E1, Benzene Exposure 
and s-PMA Benzena Metabolite 
Variables
s-PMA
<2 ug/g creatinine
s-PMA
 25 ug/g creatinine OR
crude 95% CI
p
n % n %
Polymorfphysm CYP4502E1
   Homozygot wild type (C1C1) 99 98.0 2 2.0 1.00
0.95-1.01 0.595    Heterozygot * (C1C2) 13 100 0 0 0.98
    Homozygot mutan* (C2C2) 1 100 0 0
Benzene exposure  in the 
workplace (passive sampler)
   <0.1ppm 103 99.0 1 1.0 1.00 0.60-
177.5
0.183
    >0.1ppm 10 90.9 1 9,1 10.3
*   addedd in the analysis
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Discussion
The range of age in our study i.e. 18-55 years, 
was greater than the results found by Kamboj et 
al9 which demonstrated 23–51 years. In contrast, 
the mean value of age in our study which showed 
33.14 years was nearly similar to Kamboj and 
Sambyal9 findings, i.e. 33.2+7.91 years. Working at 
the production division had higher risk of benzene 
exposure than working at the office. Petrol workers 
who work at the gasoline station had higher 
risk of benzene exposure compare to common 
population.2,8,9 The mean value of length of work 
in our study was 10.04 years ranging from 1–34 
years. In our study, the length of work of 1-10 years 
was the major findings (75.6%).
The results greater proportion in wild type 
homozygote C1C1 was similar to the findings 
in Turkey which found the proportion of genetic 
polymorphism for wild-type homozygote C1C1 
of 96.07% and C1C2 heterozygote of 3.93%.10 
Moreover, similar results were also found in 
Guangzhouhans, China, with greatest proportion 
for wild-type homozygote C1C1 as great as 67.3%, 
followed by 29.3% heterozygote C1C2 and 3.4% 
mutant homozygote C2C2.11 
Considering such results, the population in 
China had nearly similar variation on CYP4502E1 
genetic polymorphism with our study, i.e. mutant 
homozygote (C2C2) polymorphism was found. Such 
findings had not been confirmed for population in 
Turkey. Mutant homozygote polymorphism (C2C2) 
was more common in China population than the 
population in our study. Such results indicate that 
there is greater quantity of mutant homozygote 
genetic polymorphism in China population compared 
to Indonesian population. The proportion of wild-type 
homozygote and heterozygote CYP4502E1 genetic 
polymorphism in Indonesia is nearly equal to those 
in Turkey and China. 
A study in Guangzhouhans, China, found 85.3% 
C1 alleles and 14.7% C2 alleles; while our study found 
93.48% C1 allele and 5.52% C2 allele. It is obvious 
that the heterozygote and mutant homozygote type 
of CYP4502E1 have mutant allele causing different 
metabolism, which lead to greater production of 
metabolites and consequently results in increased 
metabolite concentration in the urine. Cytochrome 
P4502E1, a liver enzyme involved in benzene 
metabolism, converted benzene to benzene oxide, 
then spontaneously metabolized to phenol.12,13 
CYP4502E1 genetic polymorphism is 
determined by dominant alleles rather than the 
received benzene exposure. The correlation 
between CYP4502E1 genetic polymorphism and 
urinary s-PMA metabolites showed that there was no 
significant difference (p=0.595; ORcrude=0.98; 95%CI 
= 0.95-1.01).  Such findings opposed the theory 
saying that CYP4502E1 genetic polymorphism 
influenced the benzene received in the body and 
converted into s-PMA metabolite in the urine. The 
influence of CYP4502E1 in metabolism is affected 
by genetic polymorphism of each individual. The 
genetic polymorphism is affected by individual race 
such as choisan, australoid, negroid, caucasoid and 
mongoloid.13,14 Different race has strong influence 
on individual genetic. In our study, there were 80% 
Javanese subjects, which were included as australoid 
race. Most of them had CYP4502E1 genetic 
polymorphism with wild-type homozygote (101 
subjects). From such results, it is understandable 
that the genetic variation was scarce and therefore 
the result could not be compared to other race. 
In our study, there is no correlation between the 
extent of benzene exposure at the workplace and the 
concentration of urinary s-PMA (p>0.05). The greater 
benzene exposure at the workplace, the greater 
concentration of urinary s-PMA will occur. Benzene 
exposure concentration received at the work place 
of less than 0.1ppm, measured by passive sampler 
and was found in most subjects (90.4%). Such 
concentration was below the threshold limit values 
of benzene exposure as recommended by ACGIH 
2008 (0.5ppm) and NIOSH (0.1ppm).3 Therefore, 
it can be understood that a very small amount of 
benzene exposure at the workplace will give little 
results in urinary s-PMA. 
Most subjects had low-exposure of benzene. 
It indicates that the work-environmental control 
conducted by the company was good enough, 
which is proven by <0.1ppm benzene concentration 
at the workplace, i.e. has been below the threshold 
limit values recommended by ACGIH.15 With a good 
control, there is lesser benzene exposure into the body. 
The lesser benzene exposure, the lesser amount of 
s-PMA metabolites produced. Although there was no 
correlation, there was 10 times greater risk to produce 
urinary s-PMA concentration above 25ug/g creatinine 
in subjects who had benzene exposure above 
0.1ppm. This was appropriate with the presumption 
that increased benzene exposure at the workplace will 
increase the concentration of urinary s-PMA. 
 Other factors that also had roles in benzene 
exposure quantity into the body were utilization of 
self-protection tool and mask. The utilized mask 
should be appropriate with the concentration of 
benzene exposure at the workplace. Appropriate 
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type of mask and cartridge will reduce benzene 
exposure for the subjects. A good mask utilization 
and appropriate cartridge removal will also reduce 
benzene exposure into the body.2-4 
 There were two subjects who had urinary 
s-PMA concentration above 25ug/g creatinine, which 
possibly caused by inappropriate/less appropriate 
mask utilization and inappropriate use of cartridge 
or inappropriate type of mask. In this case, the most 
possible cause was inappropriate cartridge use, i.e. 
the cartridge had not been removed although it had 
become saturated. As a result, the benzene fume 
was inhaled into the body which caused increased 
metabolites in the body leading to increased urinary 
s-PMA. All process of benzene metabolism in the 
body is affected by CYP4502E1 enzyme.1-4 The 
greater domination of wild-type homozygote causes 
the more likely metabolism to produce lesser S-PMA 
metabolites. In contrast, when there is mutant 
homozygote, the greater result of s-PMA metabolism 
will occur. The genetic polymorphism of CYP4502E1 
is distributed according to alleles, segregated and 
transmitted to the next generation in keeping with 
the Mendel Law and could not have rapid alteration, 
which requires a very long evolution time (10-7 per 
years per cell cycle).15
 There is no correlation between age and the 
concentration of urinary s-PMA (p>0.05), despite 
the greater age will increase the risk of elevated 
concentration of urinary s-PMA (ORcrude=2,3; 
95%CI: 0.09-26.71). Moreover, the type of work, 
length of work, history of work, body mass index, 
antioxidants intake, behavior and management 
had no correlation with the concentration of urinary 
s-PMA. Such things could be understood since the 
measurement of urinary s-PMA was performed on 
the same day with the impact of benzene exposure. 
After being exposed to benzene for 8-9 hours, the 
benzene will be metabolized in the liver and will 
be excreted immediately in the urine in the form 
of s-PMA.2 Working at the production division will 
have risk of benzene exposure causing possible 
increase of urinary s-PMA concentration; however, 
the concentration of benzene in our study was very 
small (<0.1ppm). Therefore, it could be said that 
the benzene exposure at the production division 
was nearly similar to the administration desk. 
 The accumulation of benzene exposure in 
the body is affected by body surface area, which 
is identical to the body mass index (BMI).8 In 
our study, 67% subjects had excessive BMI and 
obesity; therefore, it can be said that all subjects 
got almost the same benzene exposure both in 
production and administration division. 
Conclusion 
The distribution of CYP4502E1 genetic 
polymorphism in workers with low-level benzene 
exposure (<1ppm) is relatively homogenous and 
most subjects (87.8%) had wild-type. A relatively 
homogenous condition of CYP4502E1 genetic 
polymorphism may cause no significant difference 
of urinary s-PMA concentration. There were 1.74% 
subjects with urinary s-PMA concentration above 
25ug/g creatinine and 98.26% subjects had urinary 
s-PMA concentration less than 25ug/g creatinine. 
There is no correlation between CYP4502E1 genetic 
polymorphism and the concentration of urinary s-PMA 
metabolites (p=0.595; ORcrude= 0.98; 95% CI=0.95-
1.01). Further studies are necessary involving a more 
various extent of ethnicity/race of the workers and the 
correlation with low-level benzene exposure.
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